Table 1 Maternal and neonatal characteristics of study participants

From: Comparison of the associations between office and home BP with placenta-mediated pregnancy complications: the BOSHI study

Variables

All participants (N = 975)

Maternal age, years (N = 973)

31.3 (4.7)

 <35 years, N (%)

716 (73.4)

 ≥35 years, N (%)

257 (26.4)

 Missing, N (%)

2 (0.2)

Height, cm

158.5 (5.2)

Pre-pregnancy body weight, kg

54.0 (8.5)

Pre-pregnancy BMI, kg/m²

21.5 (3.1)

 Underweight (<18.5 kg/m²), N (%)

124 (12.7)

 Normal weight (18.5–24.9 kg/m²), N (%)

735 (75.4)

 Overweight/Obese (≥25.0 kg/m²), N (%)

116 (11.9)

Parity, N (%)

 Primipara

587 (60.2)

 Multipara without HDP in a previous pregnancy

356 (36.5)

 Multipara with HDP in a previous pregnancy

20 (2.1)

 Missing

12 (1.2)

ART, N (%)

27 (2.8)

Family history of hypertension, N (%)

50 (5.1)

Smoking status, N (%)

 No smoking before conception

824 (84.5)

 Until conception was recognized

120 (12.3)

 Smoking during pregnancy

31 (3.2)

Alcohol drinking, N (%)

 No alcohol intake before conception

518 (53.1)

 Until conception was recognized

349 (35.8)

 Alcohol intake during pregnancy

99 (10.2)

 Missing

9 (0.9)

HbA1c before 20 weeks of gestation, % (N = 957)

5.0 (0.3)

Season of estimated date of confinement, N (%)

 Spring

242 (24.8)

 Summer

246 (25.2)

 Autumn

252 (25.8)

 Winter

235 (24.1)

Hyperthyroidism, N (%)

7 (0.7)

Hypothyroidism, N (%)

2 (0.2)

Chronic kidney disease, N (%)

0 (0.0)

Gestational age when office BP was measured, weeks

13.9 (2.3)

Gestational age when home BP was measured, weeks

14.0 (2.2)

Number of office BP measurements, median (range)

2 (1–2)

Number of home BP measurements, median (range)

3 (1–7)

Office SBP before 20 weeks of gestation, mmHg

108 (10)

Office DBP before 20 weeks of gestation, mmHg

66 (8)

Office MAP before 20 weeks of gestation, mmHg

80 (8)

Home SBP before 20 weeks of gestation, mmHg

104 (9)

Home DBP before 20 weeks of gestation, mmHg

63 (7)

Home MAP before 20 weeks of gestation, mmHg

77 (7)

PMPCs, N (%)

170 (17.4)

 New-onset HDP, N (%)

92 (9.4)

  Preeclampsia, N (%)

17 (1.7)

  Gestational hypertension, N (%)

75 (7.7)

 Placental abruption, N (%)

3 (0.3)

 Preterm delivery (<37 weeks of gestation), N (%)

29 (3.0)

 SGA infants (Birth weight <10th percentile), N (%)

65 (6.7)

 Stillbirth at ≥28 weeks of gestation, N (%)

2 (0.2)

Redefined PMPCs by replacing new-onset HDP with preeclampsia, N (%)

103 (10.6)

Infant sex, N (%)

 Male

507 (52.0)

 Female

468 (48.0)

Delivery week, weeks

39.6 (1.7)

Infant birth weight, g

3,053 (420)

 Low birth weight (<2,500 g), N (%)

70 (7.2)

  1. Unless otherwise specified, continuous and categorical variables are expressed as mean (s.d.) and numbers (percentages), respectively
  2. PMPCs include at least one of the following perinatal outcomes: new-onset HDP, placental abruption, spontaneous preterm delivery, SGA infants, and stillbirth at ≥28 weeks of gestation
  3. ART assisted reproductive technology, BMI body mass index, BP blood pressure, DBP diastolic blood pressure, HDP hypertensive disorders of pregnancy, MAP mean arterial pressure, PMPCs placenta-mediated pregnancy complications, SBP systolic blood pressure, s.d. standard deviation, SGA small for gestational age